z-logo
open-access-imgOpen Access
The Management of Infection and Colonization due to Methicillin‐Resistant Staphylococcus aureus: A CIDS/CAMM Position Paper
Author(s) -
Andrew E. Simor,
Mark Loeb,
the CIDS CAMM Guidelines Committee
Publication year - 2004
Publication title -
canadian journal of infectious diseases and medical microbiology
Language(s) - English
Resource type - Journals
eISSN - 1918-1493
pISSN - 1712-9532
DOI - 10.1155/2004/531434
Subject(s) - carriage , staphylococcus aureus , methicillin resistant staphylococcus aureus , medicine , infection control , antimicrobial , intensive care medicine , mupirocin , colonization , outbreak , microbiology and biotechnology , biology , virology , bacteria , pathology , genetics
Methicillin-resistant Staphylococcus aureus (MRSA) is being seen with greater frequency in most hospitals and other health care facilities across Canada. The organism may cause life-threatening infections and has been associated with institutional outbreaks. Several studies have confirmed that MRSA infection is associated with increased morbidity and mortality compared with infections caused by susceptible strains, even when the presence of comorbidities is accounted for. Treatment of MRSA infection is complicated by the fact that these organisms are resistant to multiple antimicrobial agents, so treatment options are limited. The effectiveness of decolonization therapy (attempting to eradicate MRSA carriage) is also uncertain. This paper reviews the medical management of MRSA infections, discusses the potential role of decolonization and provides an overview of evidence to support recommended infection control practices.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.
Having issues? You can contact us here
Accelerating Research

Address

John Eccles House
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom